The association of objective response and overall survival in patients with inoperable or metastatic gastric and esophagogastric junction (EGJ) cancer: A pooled analysis of individual patient data from first-line clinical trials.

被引：0
|
作者：
Bolt, Toki Anna
Pauligk, Claudia
Werner, Dominique
Mayer, Frank
Hofheinz, Ralf Dieter
Homann, Nils
Luley, Kim
Al-Batran, Salah-Eddin
机构：
[1] UCT Univ Canc Ctr, Krankenhaus Nordwest, Frankfurt, Germany
[2] Univ Hosp, Med Ctr 2, Tubingen, Germany
[3] Univ Med Ctr Mannheim, Dept Hematol & Med Oncol, Mannheim, Germany
[4] Klinikum Wolfsburg, Wolfsburg, Germany
[5] Univ Klinikum Lubeck, Lubeck, Germany
[6] Krankenhaus NW Frankfurt, Frankfurt, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4095
引用
收藏
页数：1
相关论文
共 50 条
  • [11] A meta-analysis of overall survival data from three randomized trials of bevacizumab (BV) and first-line chemotherapy as treatment for patients with metastatic breast cancer (MBC)
    O'Shaughnessy, J.
    Miles, D.
    Gray, R. J.
    Dieras, V.
    Perez, E. A.
    Zon, R.
    Cortes, J.
    Zhou, X.
    Phan, S.
    Miller, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [12] Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With Metastatic Colorectal Cancer
    Sargent, Daniel J.
    Koehne, Claus Henning
    Sanoff, Hanna Kelly
    Bot, Brian M.
    Seymour, Matthew T.
    de Gramont, Aimery
    Porschen, Ranier
    Saltz, Leonard B.
    Rougier, Philippe
    Tournigand, Christopher
    Douillard, Jean-Yves
    Stephens, Richard J.
    Grothey, Axel
    Goldberg, Richard M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) : 1948 - 1955
  • [13] Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database
    Shi, Qian
    de Gramont, Aimery
    Grothey, Axel
    Zalcberg, John
    Chibaudel, Benoist
    Schmoll, Hans-Joachim
    Seymour, Matthew T.
    Adams, Richard
    Saltz, Leonard
    Goldberg, Richard M.
    Punt, Cornelis J. A.
    Douillard, Jean-Yves
    Hoff, Paulo M.
    Hecht, Joel Randolph
    Hurwitz, Herbert
    Diaz-Rubio, Eduardo
    Porschen, Rainer
    Tebbutt, Niall C.
    Fuchs, Charles
    Souglakos, John
    Falcone, Alfredo
    Tournigand, Christophe
    Kabbinavar, Fairooz F.
    Heinemann, Volker
    Van Cutsem, Eric
    Bokemeyer, Carsten
    Buyse, Marc
    Sargent, Daniel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (01) : 22 - U47
  • [14] Effect of subsequent chemotherapy on overall survival in first-line chemotherapy with targeted agents for patients with metastatic colorectal cancer: Systematic review and meta-analysis of randomized control trials.
    Sakai, Daisuke
    Kudo, Toshihiro
    Kato, Aya
    Sueda, Toshinori
    Takahashi, Hidekazu
    Haraguchi, Naotsugu
    Nishimura, Junichi
    Hata, Taishi
    Matsuda, Chu
    Mizushima, Tsunekazu
    Doki, Yuichiro
    Mori, Masaki
    Satoh, Taroh
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [15] Quality of Life as a Prognostic Indicator of Survival: A Pooled Analysis of Individual Patient Data From Canadian Cancer Trials Group Clinical Trials
    Ediebah, Divine E.
    Quinten, Chantal
    Coens, Corneel
    Ringash, Jolie
    Dancey, Janet
    Zikos, Efstathios
    Gotay, Carolyn
    Brundage, Michael
    Tu, Dongsheng
    Flechtner, Hans-Henning
    Greimel, Eva
    Reeve, Bryce B.
    Taphoorn, Martin
    Reijneveld, Jaap
    Dirven, Linda
    Bottomley, Andrew
    CANCER, 2018, 124 (16) : 3409 - 3416
  • [16] Overall survival of men with metastatic castration-resistant prostate cancer (mCRPC) receiving first-line docetaxel-containing chemotherapy according to their participation (or not) in clinical trials.
    Goyal, Jatinder
    Huang, Peng
    Tyagi, Prachi
    Oh, Daniel
    Carducci, Michael Anthony
    Eisenberger, Mario A.
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [17] Optimal maintenance treatment strategy following an anti-EGFR-based first-line induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of clinical trials
    Raimondi, A.
    Morano, F.
    Trarbach, T.
    Karthaus, M.
    Lonardi, S.
    Fruehauf, S.
    Cremolini, C.
    Graeven, U.
    Bittoni, A.
    Mueller, L.
    Bianchi, A. Sartore
    Aranda, E.
    Boige, V.
    Stintzing, S.
    Di Bartolomeo, M.
    Koenig, A.
    Pietrantonio, F.
    Modest, D.
    ANNALS OF ONCOLOGY, 2022, 33 : S366 - S366
  • [18] EFFICACY AND SAFETY OF BEVACIZUMAB IN METASTATIC COLORECTAL CANCER (MCRC): FIRST-LINE ANALYSIS OF POOLED DATA FROM RANDOMIZED CONTROLLED TRIALS (RCTS)
    Kabbinavar, F. F.
    Hurwitz, H. I.
    Tebbutt, N. C.
    Giantonio, B. J.
    Guan, Z.
    Mitchell, L.
    Waterkamp, D.
    Tabernero, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 189 - 189
  • [19] Impact on survival of primary tumor resection in patients with colorectal cancer and unresectable metastasis: Pooled analysis of individual patients' data from four randomized trials.
    Faron, Matthieu
    Bourredjem, Abderrahmane
    Pignon, Jean-Pierre
    Bouche, Olivier
    Douillard, Jean-Yves
    Adenis, Antoine
    Elias, Dominique
    Ducreux, Michel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [20] Association of progression-free survival and overall response rate with overall survival in first-line randomized trials of immune checkpoint inhibitor-based regimens for metastatic non-small cell lung cancer (NSCLC): An FDA pooled analysis.
    Goulart, Bernardo Haddock Lobo
    Mushti, Sirisha
    Chatterjee, Somak
    Larkins, Erin A.
    Donoghue, Martha Boeri
    Tang, Shenghui
    Pazdur, Richard
    Mishra-Kalyani, Pallavi Shruti
    Beaver, Julia A.
    Singh, Harpreet
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345